Androgen Receptor Gene Amplification in Prostate Cancer
Author Information
Author(s): Edwards J, Krishna N S, Grigor K M, Bartlett J M S
Primary Institution: Glasgow Royal Infirmary
Hypothesis
AR gene amplification is involved in the development of hormone-resistant prostate cancer.
Conclusion
The study confirms that AR gene amplification is associated with the development of hormone resistance in 20% of patients and this is related to an increase in AR expression in the majority of cases.
Supporting Evidence
- AR gene amplification is present in 20-30% of hormone-resistant tumors.
- A significant increase in AR gene amplification rates is seen in the transition from hormone-sensitive to hormone-resistant disease.
- 80% of cases with AR amplification also exhibited an increase in AR expression.
Takeaway
This study looked at how the androgen receptor changes in prostate cancer. It found that some tumors become resistant to treatment because they have more copies of the androgen receptor gene.
Methodology
The study analyzed paired hormone-sensitive and hormone-resistant tumors from 51 patients using fluorescence in situ hybridization and immunohistochemistry.
Potential Biases
Potential bias in patient selection and retrospective analysis.
Limitations
The study only included a specific patient cohort and may not represent all prostate cancer cases.
Participant Demographics
Mean patient age at diagnosis was 69 years, with a range of 41 to 83 years.
Statistical Information
P-Value
p=0.0085
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website